Evaluation of Galcanezumab for the Prevention of Episodic Migraine
Author:
Affiliation:
1. Eli Lilly and Company, Indianapolis, Indiana
2. Department of Neurology, Mayo Clinic, Phoenix, Arizona
3. Department of Neurology, Georgetown University, Washington, DC
4. University of Maryland School of Medicine, Baltimore
Publisher
American Medical Association (AMA)
Subject
Clinical Neurology
Link
http:///jamaneurology/article-pdf/75/9/1080/17623592/jamaneurology_stauffer_2018_oi_180032.pdf
Reference29 articles.
1. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.;GBD 2015 Disease and Injury Incidence and Prevalence Collaborators;Lancet,2016
2. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.;GBD 2015 Neurological Disorders Collaborator Group;Lancet Neurol,2017
3. Migraine prevalence, disease burden, and the need for preventive therapy.;Lipton;Neurology,2007
4. Preventive pharmacotherapy in migraine.;Rizzoli;Headache,2014
5. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II).;Blumenfeld;Headache,2013
Cited by 438 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population;The Journal of Headache and Pain;2024-09-12
2. Effectiveness and Tolerability of Anti-Calcitonin Gene-Related Peptide Therapy for Migraine and Other Chronic Headaches in Adolescents and Young Adults: A Retrospective Study in the USA;Brain Sciences;2024-08-30
3. Assessment of Bone Mineral Density Over 1 Year in a Cross-Sectional Cohort of Migraine Patients Receiving Anti-CGRP Monoclonal Antibodies;CNS Drugs;2024-08-22
4. Evidence‐based review and frontiers of migraine therapy;Neurogastroenterology & Motility;2024-08-12
5. Calcitonin Gene-Related Peptide Inhibitors in the Treatment of Migraine in the Pediatric and Adolescent Populations: A Review;Pediatric Neurology;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3